Gainers
- Immunic IMUX shares moved upwards by 28.3% to $2.04 during Monday's after-market session. Trading volume for this security closed at 2.3 million, accounting for 418.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $90.9 million.
- Akero Therapeutics AKRO shares moved upwards by 21.54% to $59.0. At the close, Akero Therapeutics's trading volume reached 127.6K shares. This is 17.4% of its average volume over the last 100 days. The market value of their outstanding shares is at $3.2 billion.
- Lexicon Pharmaceuticals LXRX stock increased by 16.99% to $1.17. Trading volume for this security closed at 865.7K, accounting for 52.6% of its average full-day volume over the last 100 days. The company's market cap stands at $286.5 million.
- Aclarion ACON shares moved upwards by 11.63% to $0.47. The market value of their outstanding shares is at $3.8 million.
- Geovax Labs GOVX stock moved upwards by 9.43% to $0.58. This security traded at a volume of 183.4K shares come close, making up 49.8% of its average volume over the last 100 days. The company's market cap stands at $15.3 million.
- 89bio ETNB shares increased by 8.17% to $16.8. The company's market cap stands at $1.2 billion.
Losers
- Ventyx Biosciences VTYX stock fell 20.4% to $23.88 during Monday's after-market session. Trading volume for this security closed at 476.0K, accounting for 86.5% of its average full-day volume over the last 100 days. The company's market cap stands at $1.4 billion.
- iSpecimen ISPC shares declined by 18.01% to $0.46. iSpecimen's trading volume hit 128.5K shares by close, accounting for 414.1% of its average volume over the last 100 days. The company's market cap stands at $4.1 million.
- Hyperfine HYPR stock declined by 11.17% to $1.75. The company's market cap stands at $124.8 million.
- Scinai Immunotherapeutics SCNI shares declined by 10.89% to $0.61. The company's market cap stands at $2.8 million.
- RVL Pharmaceuticals RVLP shares declined by 9.12% to $0.17. RVL Pharmaceuticals's trading volume hit 12.1 million shares by close, accounting for 99.7% of its average volume over the last 100 days. The market value of their outstanding shares is at $19.3 million.
- Vaccinex VCNX stock declined by 7.7% to $1.08. Vaccinex's trading volume hit 659.9K shares by close, accounting for 140.3% of its average volume over the last 100 days. The market value of their outstanding shares is at $5.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in